As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Former X CEO and senior NBCUniversal executive Linda Yaccarino has been named CEO of digital weight-loss firm eMed.

For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with ...

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, ...

A Massachusetts biotech working on a class of medicines called circular RNA therapeutics beat out companies from around the ...